Literature DB >> 18762974

Splenomegaly, hypersplenism and peripheral blood cytopaenias in patients with classical Anderson-Fabry disease.

João Paulo Oliveira1, Carmen Valbuena, António Baldaia Moreira, Elsa Fonseca, Carlos Soares, Elisa Leão Teles, Stephen Waldek.   

Abstract

A 39-year-old male with classical Anderson-Fabry disease (AFD) and long-standing idiopathic splenomegaly, who had been on haemodialysis since the age of 24, was splenectomised for symptomatic pancytopaenia. Spleen enlargement was first noted at clinical presentation, at age 16, but despite thorough investigation its cause remained unclear. Anaemia, leukopaenia and thrombocytopaenia were first observed a few years thereafter, but well before the start of dialytic treatment. On gross pathological examination the spleen weighed 700 g and had a fibrocongestive appearance. Histologically, it showed expansion of the red pulp and decreased white pulp. Some histiocytes and many of the endothelial cells lining the sinusoids had vacuolated cytoplasm with argyrophilic material within, suggesting their involvement in the storage pathology of AFD. In a retrospective review of our cohort of patients with classical AFD (n = 10), complete blood counts showing anaemia, leukopaenia or thrombocytopaenia were found in five, two and four patients, respectively, including a 6-year-old boy, whose spleen was also enlarged. Data from AFD international registries show that peripheral blood cytopaenias, particularly anaemia, are prevalent among these patients. Sinusoidal endothelial involvement resulting in compromise of splenic blood flow may be the cause of congestive splenomegaly and hypersplenism in classical AFD.

Entities:  

Mesh:

Year:  2008        PMID: 18762974     DOI: 10.1007/s00428-008-0651-4

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.535


  43 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  'Isolated' thrombocytopenia by splenic sequestration in hemodialyzed patients.

Authors:  A Verzola; G L Scapoli; I S Risichella; N Prandini; M Rigolin; M Bergami; P Gilli; P L Bedani
Journal:  Nephron       Date:  2000-10       Impact factor: 2.847

3.  The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.

Authors:  J Charrow; H C Andersson; P Kaplan; E H Kolodny; P Mistry; G Pastores; B E Rosenbloom; C R Scott; R S Wappner; N J Weinreb; A Zimran
Journal:  Arch Intern Med       Date:  2000-10-09

4.  Morphologic and immunohistochemical evaluation of splenic hematopoietic proliferations in neoplastic and benign disorders.

Authors:  Dennis P O'Malley; Young S Kim; Sherrie L Perkins; LeeAnn Baldridge; Beth E Juliar; Attilio Orazi
Journal:  Mod Pathol       Date:  2005-12       Impact factor: 7.842

5.  Angiokeratoma corporis diffusum universale (Fabry).

Authors:  R D Wallace; W J Cooper
Journal:  Am J Med       Date:  1965-10       Impact factor: 4.965

6.  The rational clinical examination. Physical examination of the liver.

Authors:  C D Naylor
Journal:  JAMA       Date:  1994-06-15       Impact factor: 56.272

7.  [Priapism associated with Fabry's disease].

Authors:  E Jaureguizar Monereo; P López Pereira; J Cabo; J M Gutiérrez; J García-Consuegra; J Martínez Olivas; M López Santamaría
Journal:  Cir Pediatr       Date:  1990-07

8.  Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis.

Authors:  L E Adinolfi; M G Giordano; A Andreana; M F Tripodi; R Utili; G Cesaro; E Ragone; E Durante Mangoni; G Ruggiero
Journal:  Br J Haematol       Date:  2001-06       Impact factor: 6.998

9.  An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients.

Authors:  Theodore E Warkentin; Robin S Roberts; Jack Hirsh; John G Kelton
Journal:  Arch Intern Med       Date:  2003-11-10

10.  Hemosiderosis in hemodialysis patients. An autopsy study of 50 cases.

Authors:  M Ali; A O Fayemi; R Rigolosi; J Frascino; T Marsden; D Malcolm
Journal:  JAMA       Date:  1980-07-25       Impact factor: 56.272

View more
  4 in total

1.  Immunohistochemical diagnosis of Fabry nephropathy and localisation of globotriaosylceramide deposits in paraffin-embedded kidney tissue sections.

Authors:  Carmen Valbuena; Dina Leitão; Fátima Carneiro; João Paulo Oliveira
Journal:  Virchows Arch       Date:  2011-12-29       Impact factor: 4.064

Review 2.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

3.  Renal variant of Fabry disease with sporadic GLA gene mutation: role of early renal biopsy.

Authors:  Suhail Al-Salam; Ahmed Chaaban; Fatima Al-Jasmi; Kerstin Amann; Samra Abouchacra
Journal:  Clin Kidney J       Date:  2012-10

4.  Natural course of Fabry disease with the p. Arg227Ter (p.R227*) mutation in Finland: Fast study.

Authors:  Päivi Pietilä-Effati; Jukka T Saarinen; Eliisa Löyttyniemi; Reijo Autio; Maria Saarenhovi; Maria K Haanpää; Ilkka Kantola
Journal:  Mol Genet Genomic Med       Date:  2019-08-14       Impact factor: 2.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.